ABOUT
Meet our Board of Directors
Experienced leaders providing strategic direction and oversight for Thryv Therapeutics as it develops next-generation precision therapies for inherited channelopathies, cardiometabolic diseases and cardiomyopathies.
Directors
Paul F. Truex, MBA
Chairman of the Board & Chief Executive Officer
Read biography →
Robert Booth, PhD
Director
Read biography →
Daniel Hétu, MD, MBA
Director
Read biography →
Melissa Koomey, MBA
Director
Read biography →
Jean-François Pariseau, MSc, MBA, ICD.D
Director
Read biography →
Amy Rudolph, PhD
Director
Marc-Olivier Sirard, CPA
Director
Observers
Youssef Bennani, PhD, MBA
Observer
Maxime Daigle, CPA
Observer
Read biography →
Sarah Williams, PhD
Observer
Scott Weiner, MBA
Observer
Read biography →